Expertise in
7
conditions

Dr. Gerald L. Andriole

Urology
Office
4960 Childrens Pl Ste 8242, 
Saint Louis, MO 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
7
conditions
Office
4960 Childrens Pl Ste 8242, 
Saint Louis, MO 

Overview

Gerald Andriole is a Urologist practicing medicine in Saint Louis, Missouri.

Dr. Andriole is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Enlarged Prostate (BPH), Prostatectomy, and Vasectomy.

He is actively involved in clinical research, co-authoring 213 peer reviewed articles and participating in 8 clinical trials.

Specialties

Urology

Licenses

Urology in MO

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO

Locations

Office
4960 Childrens Pl Ste 8242, Saint Louis, MO 63110

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

Diffusion Basis Spectrum Imaging of the Prostate: A Virtual Biopsy to Accurately Diagnose Prostate Cancer
Diffusion Basis Spectrum Imaging of the Prostate: A Virtual Biopsy to Accurately Diagnose Prostate Cancer
Enrollment Status: Recruiting
Publish Date: July 14, 2026
Intervention Type: Device
Study Phase: Not Applicable
A Phase 2 Study of Ibrutinib as Neoadjuvant Therapy in Patients With Localized Prostate Cancer
A Phase 2 Study of Ibrutinib as Neoadjuvant Therapy in Patients With Localized Prostate Cancer
Enrollment Status: Completed
Publish Date: January 08, 2025
Intervention Type: Procedure, Drug
Study Drug: Ibrutinib
Study Phase: Phase 2
A Study of MRI/US Fusion Imaging and Biopsy in Combination With Nanoparticle Directed Focal Therapy for Ablation of Prostate Tissue
A Study of MRI/US Fusion Imaging and Biopsy in Combination With Nanoparticle Directed Focal Therapy for Ablation of Prostate Tissue
Enrollment Status: Unknown
Publish Date: May 18, 2023
Intervention Type: Device
Study Phase: Not Applicable
Trans-MAPP Study of Urologic Chronic Pelvic Pain: Control Study Protocol
Trans-MAPP Study of Urologic Chronic Pelvic Pain: Control Study Protocol
Enrollment Status: Completed
Publish Date: August 05, 2022
A PrOspective Phase 2/3 Multi-Center Study of 18F-DCFPyL PET/CT Imaging in Patients With PRostate Cancer: Examination of Diagnostic AccuracY (OSPREY)
A PrOspective Phase 2/3 Multi-Center Study of 18F-DCFPyL PET/CT Imaging in Patients With PRostate Cancer: Examination of Diagnostic AccuracY (OSPREY)
Enrollment Status: Completed
Publish Date: August 09, 2021
Intervention Type: Diagnostic test, Drug
Study Phase: Phase 2/Phase 3
MAPP Research Network: Trans-MAPP Study of Urologic Chronic Pelvic Pain: Symptom Patterns Study (SPS)
MAPP Research Network: Trans-MAPP Study of Urologic Chronic Pelvic Pain: Symptom Patterns Study (SPS)
Enrollment Status: Completed
Publish Date: July 09, 2020
A Phase 3 Study to Evaluate the Safety and Efficacy of 99mTc-MIP-1404 SPECT/CT Imaging to Detect Clinically Significant Prostate Cancer in Men With Biopsy Proven Low-Grade Prostate Cancer Who Are Candidates for Active Surveillance (proSPECT-AS)
A Phase 3 Study to Evaluate the Safety and Efficacy of 99mTc-MIP-1404 SPECT/CT Imaging to Detect Clinically Significant Prostate Cancer in Men With Biopsy Proven Low-Grade Prostate Cancer Who Are Candidates for Active Surveillance (proSPECT-AS)
Enrollment Status: Completed
Publish Date: April 10, 2019
Intervention Type: Drug, Diagnostic test
Study Phase: Phase 3
Symptoms of Lower Urinary Tract Dysfunction Research Network (LURN) Phenotyping Study Protocol
Symptoms of Lower Urinary Tract Dysfunction Research Network (LURN) Phenotyping Study Protocol
Enrollment Status: Completed
Publish Date: January 15, 2019
Intervention Type: Procedure, Other
View 7 Less Clinical Trials

212 Total Publications

Validation of the Prostatype® P-score for predicting prostate cancer specific mortality in a multiethnic U.S. veterans cohort.
Validation of the Prostatype® P-score for predicting prostate cancer specific mortality in a multiethnic U.S. veterans cohort.
Journal: Prostate cancer and prostatic diseases
Published: July 30, 2025
Similar Doctors
Expertise in
31
conditions
Expertise in
31
conditions
Referral may be required

Office

4960 Childrens Pl, 
Saint Louis, MO 
 (0.8 miles away)
314-362-8200
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Robert Figenshau is a Urologist practicing medicine in Saint Louis, Missouri. Dr. Figenshau is highly rated in 31 conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Ureterocele, Prostate Cancer, Nephrectomy, and Lithotripsy. Dr. Figenshau is currently accepting new patients.

Expertise in
18
conditions
Expertise in
18
conditions
Referral may be required

SLUCare Physician Group

6400 Clayton Road, Suite 201, 
St. Louis, MO 
 (2.4 miles away)
314-617-3880
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Dr. Zachary Hamilton specializes in the surgical and medical treatment of urologic cancers, including kidney, testicular, prostate, penile, adrenal, and urothelial cancers. He performs procedures that include: radical and partial nephrectomy; cystectomy; neobladder; adrenalectomy; radical and partial penectomy; prostatectomy; and retroperitoneal lymph node dissection. He has extensive experience in robotic surgery and minimally invasive techniques. Dr. Hamilton has published numerous papers and has an extensive research portfolio, including an interest in health outcomes research regarding the surgical treatment of kidney and bladder cancer. Dr. Hamilton is the division director and associate professor in the Department of Surgery, Division of Urologic Surgery, at Saint Louis University School of Medicine. He serves on multiple hospital and regional committees, including at the School of Medicine. He is a member of the American Urological Association, Society of Urologic Oncology, Society of Robotic Surgery, Alpha Omega Alpha Honor Society, and the Gold Humanism Honor Society. Dr. Hamilton is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Prostate Cancer, WT1-Related Wilms Tumor Syndromes, Nephrectomy, and Reconstructive Urology Surgery. Dr. Hamilton is board certified in American Board Of Urology , Missouri Dept Of Health/Narcotics&Dangerous Drugs , Missouri State Board Of Registration, and Drug Enforcement Administration . Dr. Hamilton is currently accepting new patients.

Expertise in
11
conditions
Expertise in
11
conditions
Referral may be required

Washington University School Of Medicine

1040 N Mason Rd, 
Saint Louis, MO 
 (11.5 miles away)
314-362-8200
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Sam Bhayani is a Urologist practicing medicine in Saint Louis, Missouri. Dr. Bhayani is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Familial Prostate Cancer, Wilms Tumor, Nephrectomy, and Reconstructive Urology Surgery. Dr. Bhayani is currently accepting new patients.

Frequently Asked Questions about Dr. Gerald L. Andriole

How do I make an appointment with Dr. Gerald L. Andriole?

You can book an appointment with Dr. Gerald L. Andriole by calling their office at 314-362-8200. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Gerald L. Andriole a top-rated expert for Prostate Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Gerald L. Andriole is classified as an Elite expert for Prostate Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Gerald L. Andriole specialize in?

While Dr. Gerald L. Andriole is a Urology, they have specific expertise in Prostate Cancer, Familial Prostate Cancer, and Enlarged Prostate (BPH). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Urology.

Does Dr. Gerald L. Andriole participate in research or clinical trials?

Yes. Dr. Gerald L. Andriole has published 212 articles and abstracts on conditions like Prostate Cancer. You can view a list of Dr. Gerald L. Andriole's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Gerald L. Andriole accept my insurance?

Dr. Gerald L. Andriole accepts most major insurance plans, including Humana. We recommend calling the office directly at 314-362-8200 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Andriole's expertise for a condition
ConditionClose
View All 31 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile